首页> 外国专利> USE OF KCNQ-OPENERS FOR THREATING OR REDUCING THE SYMPTOMS OF SCHIZOPHRENIA

USE OF KCNQ-OPENERS FOR THREATING OR REDUCING THE SYMPTOMS OF SCHIZOPHRENIA

机译:使用KCNQ开放剂缓解或减少精神分裂症的症状

摘要

196 USE OF KCNQ-OPENERS FOR THREATING OR REDUCING THE SYMPTOMS OF SCHIZOPHRENIA ABSTRACT 5 THE INVENTION RELATES TO A NOVEL METHOD FOR TREATING OR REDUCING THE SYM TOMS OF . P SCHIZOPHRENIA. SAID METHOD COMPRISING ADMINISTERING TO A HOST IN NEED THEREOF AN EFFECTIVE AMOUNT OF A COMPOUND ABLE TO SELECTIVELY INCREASE THE ION FLOW THROUGH KCNQ POTASSIUM CHANNELS. FURTHERMORE THE INVENTION RELATES TO THE INE OF SELECTIVE 1 0 KCNQ POTASSIUM CHANNEL OPENERS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATING OR REDUCING THE SYMTOMS OF SCHIZOPHRENIA AND RELATED SVM TOMS. DISORDERS AND DISEASES. FURTHERMORE THE INVENTION RELATES TO A METHOD OF @ P SCREENING FOR A COMPOUND, WHICH IS A SELECTIVE KCNQ POTASSIUM CHANNEL OPENER AND WHICH IS CAPABLE OF HAVING AN ANTI-PSYCHOTIC POTENTIAL.
机译:196使用KCNQ-开放剂治疗或减少精神分裂症摘要的症状5本发明涉及用于治疗或减少精神分裂症的症状的新颖方法。 P精神分裂症。一种有效的组合物,可有效减少需要通过KCNQ钾离子通道的离子流的化合物。另外,本发明涉及用于制备药物组合物的选择性的1 0 KCNQ钾通道开启剂,该药物组合物用于治疗或减少精神分裂症的症状和相关的SVM症状。疾病和疾病。进一步,本发明涉及一种对化合物进行@P筛选的方法,该化合物是选择性的KCNQ钾通道开放剂,并且具有抗磷脂的潜力。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号